Clinical Trials Sponsored by Astellas Pharma US, Inc.

Total 1234 results

Astellas Pharma Inc

Completed

Safety and Effectiveness of Repeated Administration of QUTENZA Patches for Treatment of Pain Caused by Nerve Damage (STRIDE)

Neuralgia, Postherpetic

France, Italy, Spain, Austria, Ireland, Belgium, United Kingdom, Romania, Slovenia, Greece, Czechia, Finland, Poland, Netherlands, Hungary, Slovakia
Astellas Pharma Inc

Completed

Specified Drug Use-results Survey of Betanis Tablets

Overactive Bladder

Japan
Astellas Pharma Inc

Completed

Study of FK463 in the Treatment of Candidemia or Invasive Candidiasis

Candidiasis

United Kingdom, Austria, France, Germany, Italy, Poland, Spain, Sweden
Astellas Pharma Inc

Completed

A Study With ASP2151 in Subjects With Recurrent Episodes of Genital Herpes

Herpes Genitalis

United States
Astellas Pharma Inc

Completed

A Study to Evaluate Pre-emptive Treatment for Invasive Candidiasis in High Risk Surgical Subjects (INTENSE)

Mycoses

Belgium, Germany, Spain, France, Italy, Turkey, Austria, Switzerland, Hungary, United Kingdom, Israel, Denmark, Greece, Finland, Romania
Astellas Pharma Inc

Completed

Clinical Study of Solifenacin Succinate in Patients With Bladder Symptoms Due to Spinal Cord Injury or Multiple Sclerosis (SONIC)

Multiple Sclerosis | Spinal Cord Diseases | Neurogenic Bladder

Australia, France, Belgium, Germany, Netherlands, Italy, Spain, United Kingdom, Hungary, Czechia, Russian Federation
Astellas Pharma Inc

Completed

Drug to Drug Interaction Study With ASP1941 and Metformin

Type 2 Diabetes Mellitus

Hungary, Poland, Slovakia, Netherlands
Astellas Pharma Inc

Completed

Zolpidem Postmarketing Study in Adolescent Patients With Insomnia

Insomnia

Japan
Astellas Pharma Inc

Completed

A Study of YM178 in Subjects With Symptoms of Overactive Bladder

Urinary Bladder, Overactive

China, Taiwan, India, Korea, Republic of
Astellas Pharma Inc

Completed

A Study of YM178 in Patients With Symptomatic Overactive Bladder

Urinary Bladder, Overactive

Japan
Astellas Pharma Inc

Completed

Study to Evaluate the Effect of Multiple-dose of Fluvoxamine on the Plasma Concentration of Quetiapine (FK949E) in Healthy Male Volunteers

Healthy | Pharmacokinetics of Quetiapine

Japan
Astellas Pharma Inc

Completed

Post-marketing Surveillance of Kiklin Capsules in Hemodialysis Patients

Chronic Renal Failure Patients With Hyperphosphataemia Receiving Hemodialysis

Japan
Astellas Pharma Inc

Completed

Study of an Investigational Drug, ASP3026, in Patients With Advanced Malignancies (Solid Tumors and B-Cell Lymphoma)

Solid Tumor | B-Cell Lymphoma | Advanced Malignancies | Positive for Anaplastic Lymphoma Kinase | Positive for Proto-Oncogene Tyrosine-Protein Kinase ROS

United States
Astellas Pharma Inc

Completed

Dose Range-finding Study of ASP1585 in Chronic Kidney Disease Patients on Hemodialysis With Hyperphosphatemia

Chronic Kidney Disease Patients on Hemodialysis With Hyperphosphatemia

Japan
Astellas Pharma Inc

Terminated

Efficacy and Safety of Dorner Tablets and Aspirin for Prevention of Arteriosclerosis Progress in Type 2 Diabetes Mellitus Patients

Type 2 Diabetes Mellitus

China
Astellas Pharma Inc

Completed

A Study to Compare the Efficacy and Safety of FK506MR vs Prograf® in Patients Undergoing Kidney Transplantation

Kidney Transplantation

China
Astellas Pharma Inc

Completed

A Study to Compare the Efficacy and Safety of FK506MR vs Prograf® in Patients Undergoing Liver Transplantation

Liver Transplantation

China
Astellas Pharma Inc

Completed

Long-term Efficacy and Safety of Gabapentin Enacarbil in Japanese Restless Legs Syndrome Patients

Restless Legs Syndrome

Japan
Astellas Pharma Inc

Completed

ASP8825 - Pharmacokinetics Study in Patients With Impaired Renal Function and Haemodialysis

Patients With Impaired Renal Function and Haemodialysis

Japan
Astellas Pharma Inc

Completed

Phase 3 Study of YM060 in Patients With Diarrhea-predominant Irritable Bowel Syndrome (d-IBS)

Irritable Bowel Syndrome

Japan
Astellas Pharma Inc

Completed

A Study to Evaluate Efficacy of YM060 on Diarrhea-predominant Irritable Bowel Syndrome (D-IBS) in Female Patients

Irritable Bowel Syndrome

Japan
Astellas Pharma Inc

Completed

An Extension Study Administering YM155 to Subjects Previously Enrolled in Another Protocol Administering YM155

Melanoma | Non-Hodgkin's Lymphoma | Prostate Cancer

United States
Astellas Pharma Inc

Terminated

Study of YM155 in Refractory Diffuse Large B-cell Lymphoma (DLBCL) Subjects

Lymphoma, Large-Cell, Diffuse | Lymphoma, B-Cell Refractory

France, Spain, United States, Canada
Astellas Pharma Inc

Completed

Comparing Efficacy and Safety of Steroid Withdrawal With Tacrolimus and MMF With Induction in Children After Kidney Transplantation (TWIST)

Kidney Transplantation

Belgium, Italy, Taiwan, France, South Africa, Turkey, Germany, United Kingdom, Hungary, Czech Republic, Romania, Sweden, Poland, Israel
Astellas Pharma Inc

Completed

Long-term Study in Chronic Kidney Disease Patients With Hyperphosphatemia Not on Dialysis

Renal Insufficiency | Chronic Kidney Disease | Hyperphosphatemia

Japan
Astellas Pharma Inc

Completed

A Comparative Study of ASP1585 in Chronic Kidney Disease Patients With Hyperphosphatemia on Hemodialysis

Renal Insufficiency | Chronic Kidney Disease | Renal Dialysis

Japan
Astellas Pharma Inc

Completed

A Study to Demonstrate Safety and Efficacy of Advagraf in Patients Undergoing Kidney or Liver Transplantation in India

Liver Transplantation | Kidney Transplantation

India
Astellas Pharma Inc

Completed

Phase II Study of ASP3550 in Patients With Prostate Cancer

Prostatic Neoplasms

Japan
Astellas Pharma Inc

Completed

ASP8825 - Study in Patients With Restless Legs Syndrome

Restless Legs Syndrome

Japan
Astellas Pharma Inc

Completed

A Comparison Study Between Protopic (Tacrolimus) Ointment and Elidel (Pimecrolimus) Cream in Treating Subjects With Atopic Dermatitis

Dermatitis, Atopic

United States, Canada
Astellas Pharma Inc

Completed

Treatment and Control of Atopic Dermatitis With 0.1% Tacrolimus Ointment

Dermatitis, Atopic

France, Germany, Spain, Belgium, Netherlands, Finland, Austria, United Kingdom, Italy, Czech Republic, Switzerland, Portugal, Denmark
Astellas Pharma Inc

Completed

A Multicenter VESIcare® Efficacy and Safety Study for the Treatment of Urgency Associated With Overactive Bladder (OAB) (VENUS)

Urinary Bladder, Overactive

United States
Astellas Pharma Inc

Completed

Comparative Trial of Micafungin Versus Fluconazole for Treating Esophageal Candidiasis

Candidiasis, Oral

South Africa, Brazil, Peru
Astellas Pharma Inc

Completed

Solifenacin Succinate 5mg or 10mg Once Daily in the Treatment of Urgency Symptoms (SUNRISE)

Urinary Bladder, Overactive

France, United Kingdom, Belgium, Germany, Spain, Portugal, Greece, Russian Federation, Czech Republic, Poland, Hungary, Italy, Slovakia, Egypt
Astellas Pharma Inc

Completed

Phase III Study of 0.1% Tacrolimus(FK506) Ophthalmic Suspension in Patients With Vernal Keratoconjunctivitis

Keratoconjunctivitis | Conjunctivitis

Japan
Astellas Pharma Inc

Completed

Study to Evaluate the Efficacy and Safety of 0.1% and 0.03% Tacrolimus Ointment Administered in Adults With Moderate to Severe Atopic Dermatitis

Dermatitis, Atopic

Italy
Astellas Pharma Inc

Completed

Clinical Trial to Assess the Efficacy and Safety of Tacrolimus Ointment Treatment of Atopic Dermatitis in Adult Patients

Dermatitis, Atopic

Poland, Czech Republic, Hungary
Astellas Pharma Inc

Completed

Comparing Efficacy & Safety of Tacrolimus With/Without MMF or Monoclonal Anti-IL2R Antibody in Liver Transplantation. (MARSILEA)

Liver Transplantation

Belgium, Germany, Italy, Switzerland, Spain, Denmark, United Kingdom, Hungary, Finland, Sweden, Poland
Astellas Pharma Inc

Completed

Tacrolimus and Daclizumab Versus Tacrolimus and Steroids in Liver Recipients Receiving Sub-optimal Grafts (PANTERA)

LIVER TRANSPLANTATION

Italy
Astellas Pharma Inc

Completed

Tacrolimus (FK506) P-III, Open-label Study in Refractory Ulcerative Colitis Patients

Ulcerative Colitis

Japan
Astellas Pharma Inc

Completed

Sequential Therapy (FK506 + Monoclonal Anti-IL2R Antibodies + MMF) Versus FK506 With Steroids in Liver TX (TAST)

Liver Transplantation

Italy
Astellas Pharma Inc

Completed

FK506 Phase 3 Study: a Study for Steroid Non-resistant Myasthenia Gravis (MG) Patients

Myasthenia Gravis

Japan
Astellas Pharma Inc

Completed

A Study With Combination Treatment (Tamsulosin Hydrochloride and Solifenacin Succinate) in Male Patients With LUTS/BPH (SATURN)

Lower Urinary Tract Symptoms | Prostatic Hyperplasia

France, Poland, Germany, Spain, Finland, Netherlands, Russian Federation, Czech Republic, Hungary, Norway, Denmark, Slovakia, Sweden, Austria, Portugal, United Kingdom
Astellas Pharma Inc

Completed

Conversion Study From Cyclosporine to FK506MR Based Immunosuppression in Kidney Transplant Subjects (CONCERTO)

Transplantation

France, Italy, Poland, Germany, Spain, Belgium, Switzerland, Finland, Czech Republic, Hungary, Austria, Denmark, Sweden
Astellas Pharma Inc

Completed

A Phase 3 Study of ASP1585 in Chronic Kidney Disease Patients With Hyperphosphatemia Not on Dialysis

Renal Insufficiency | Chronic Kidney Disease | Hyperphosphatemia

Japan
Astellas Pharma Inc

Completed

A Conversion Study to Assess Safety and Efficacy of a MR4 Based Immunosuppressive Regimen in Stable Liver Recipients

Transplantation

France, Spain, Germany, United Kingdom, Ireland, Poland
Astellas Pharma Inc

Completed

A Study to Evaluate the Safety and Efficacy of FK506E (MR4) in Patients Undergoing Primary Liver Transplantation.

Liver Transplantation

France, Italy, Poland, Belgium, Spain, Germany, Switzerland, Canada, Finland, Brazil, Czech Republic, Australia, Norway, Sweden, United Kingdom, Ireland
Astellas Pharma Inc

Completed

A Study to Evaluate the Safety and Efficacy of FK506E (MR4) in Patients Undergoing Primary Kidney Transplantation

Kidney Transplantation

Australia, France, United Kingdom, Germany, Spain, Argentina, South Africa, Switzerland, Canada, Finland, Greece, Netherlands, Brazil, Belgium, Poland, Hungary, Czech Republic, Austria, Ireland, Italy, Mexico, Norway, Sweden
Astellas Pharma Inc

Terminated

A Study to Evaluate the Effect of ASP8597 in Adult Kidney Transplant Patients

Kidney Transplantation

United States
Astellas Pharma Inc

Completed

Study of an Investigational Drug, ASP3026, in Patients With Solid Tumors

Solid Tumor

Japan

Clinical Trials Sponsored by Astellas Pharma US, Inc.

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Luxembourg

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations